Abstract
We have generated transgenic mice which express the gene encoding Escherichia coli nitro reductase (NTR) specifically in the luminal epithelial cells of the mammary gland and the glial cells of the brain. The enzyme activates an antitumour drug CB1954, to produce a cross-linking agent that kills all cells expressing the enzyme. We have shown that administration of the antitumour drug CB 1954 rapidly and selectively kills these cells. Original experiments demonstrated the ability to ablate the luminal cells in the mammary gland with no apparent bystander effect. Subsequently, astrocytes expressing nitroreductase under the targeting of the GFAP promoter were selectively ablated following administration of the prodrug CB 1954 produces a degeneration of granular neurones due to changes in glutamate levels. Recent experiments demonstrated inhibition of myc-dependent mammary tumours using the same enzyme (nitroreductase) — prodrug (CB 1954), combination. Owing to the ease of control of NTR-mediated cell ablation, we anticipate that this system will supersede herpes simplex virus type 1 thymidine kinase. There are Widespread potential applications for this approach in the dissection of complex cellular interactions during development and in the adult organism. The present transgenic models also have important applications for the study in vivo of novel prodrugs that can be selected for variable degrees of bystander effects. Such studies will have particular significance for those groups advocating the use of NTR as an appropriate enzyme for gene-directed enzyme prodrug therapy by providing models of a wide range of human disease for mechanistic and therapeutic experimentation. The results clearly demonstrate that the model has potential to study chemoprevention and fundamental questions on cell-cell interactions in cell biology.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
AI-Shaw R, Burke J, Wallace H, Joes C, Harrison S, Buxton D, Maley S, Chandley A, Bishop J (1991) The herpes simplex virus type I thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter. Mol Cell Biol 11:4207–4216
Anlezark GM, Melton RG, Sherwood RF, Coles B, Friedlos F, Knox RJ (1992) The bioact ivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954). I. Purification and properties of a nitro reductase enzyme for Escherichia coli-a potential enzyme for antibody directed enzyme prodrug therapy (ADEPT). Biochem Pharmacol 44:2289–2295
Archibald AL, McClenaghan M, Homsey V, Simons JP, Clark AJ (1990) Expression of biologically active human α1-antitrypsin in the milk of transgenic mice. Proc Natl Acad Sci USA 87:5178–5182
Baptista CA, Hatten ME, Blazeski R, Mason CA (1994) Cell-cell interactions influence survival and differentiation of purified Purkinje cells in vitro. Neuron 12:243–260
Behringer RR, Mathews LS, Palmiter RD, Brinster RL (1988) Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 2:453–461
Bernstein A, Breitman M (1989) Genetic ablation in transgenic mice. Molecular Biol Med 6:523–530
Borrelli E, Heyman RA, Arias C, Sawchenko PE, Evans RM (1989) Transgenic mice with inducible dwarfism. Nature 339:538–541
Bradl M, Larue L, Mintz B (1991) Mosaic expression of a tyrosinase fusion gene in albino mice yields a heritable striped coat colour pattern in transgenic homozygotes. Proc Natl Acad Sci USA 88: 9643–9647
Bridgewater JA, Springer CJ, Knox RJ (1995) Expression of nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB 1954. Eur J Cancer 31A:2362–2370
Bridgewater JA, Knox RJ, Pitts JD, Collins MK, Springer CT (1997) The bystander effect of the nitroreductase/CB 1954 enzyme/prodrug system is due to a cell-permeable metabolite. Hum Gene Ther 8:709–717
Burrows HL, Birkmeier TS, Seasholtz AF, Camper SA (1996) Targeted ablation of cells in the pituitary primordia of transgenic mice. Mol Endocrinoll 10:1467–1477
Bush TG, Savidge TC, Freeman TC, Cox HJ, Campbell EA, Micke L, Johnson MH, Sofroniew MV (1998) Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93:189–201
Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV (1999) Leukocyte infiltration, neuronal degenerat ion and neurite outgrowth after ablation of scar-forming reactive astrocytes in adult transgenic mice. Neuron 23:297–308
Canfield V, West AB, Goldenring JR, Levenson R (1996) Genetic ablation of parietal cells in transgenic mice: a new model for analysing cell lineage relationship in the gastric mucosa. Proc Natl Acad Sci USA 93:2431–2435
Cardiff RD, Anver MR, Gusterson BA, Henninghausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FT, Wakefield LM, Ward JM, Green JE (2000) The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19:968–988
Chen S, Knox R, Lewis AD, Friedlos F, Workman P, Deng PS, Fung M, Ebenstein D, Wu K, Tsai TM (1995) Catalytic properties of NAD(P):quinone acceptor oxidoreductase: study involving mouse, rat, human and mouse-rat-chimeric enzymes. Mol Pharmacol 44:2297–2301
Clark AJ, Cowper A, Wallace R, Wright G, Simons JP (1992) Rescuing transgene expression by cointegration. Biotechnology (NY) 10:1450–1454
Clark AJ, Iwobi M, Cui W, Crompton M, Harold G, Hobbs S, Kamalati R, Knox R, Neil C, Yull F, Gusterson B (1997) Selective cell ablation in transgenic mice express E.coli nitroreductase. Gene Ther 4:101–110
Collier RJ (1975) Diphtheria toxin: mode of action and structure. Bacteriol Rev 39:54–85
Cui W, Gusterson B, Clark AJ (1999) Nitroreductase-mediated cell ablation is very rapid and mediated by a p53-independent apoptotic pathway. Gene Ther 6:764–770
Cui W, Gusterson B, Clark AJ (2001) Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain. Glia 34:272–282
Cui W, Gusterson B, Clark AJ (2002) Inhibition of MYC-dependent breast tumour formation in transgenic mice. Breast Cancer Res Treat 71:9–20
Delaney CL, Brenner M, Messing A (1996) Conditional ablation of cerebellar astrocytes in postnatal transgenic mice. J Neurosci 16:6908–6918
Dobie KW, Lee M, Fantes JA, Graham E, Clark AJ, Springbett A, Lathe RL, McClenaghan M (1996) Variegated expression in mouse mammary gland is determined by the transgene integration locus. Proc Natl Acad Sci USA 93:6659–6664
Drabek D, Guy I, Craig R, Grosveld F (1997) The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB 1954. Gene Ther 4:93–100
Eddleston M, Mucke L (1993) Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience 54:15–36
Elliot JI, Festenstein R, Tolaini M, Kioussis D (1995) Random activation of a transgene under the control of a hybrid CD2 locus control region/Ig enhancer regulatory element. EMBOJ 14:575–584
Festenstein R, Tolaini M, Corbella P, Mamalaki C, Parrington J, Fox M, Miliou A, Jones M, Kioussis D (1996) Locus control region function and heterochromatin induced position effect variegation. Science 271:1123–1125
Friedlos F, Court S, Ford M, Denny WA, Springer C (1998) Gene-directed enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB 1954 in cells expressing bacterial nitroreductase. Gene Ther 5:105–112
Green NK, Youngs DJ, Neoptolemos JP, Friedlos F, Knox RI, Springer CJ, Anlezark GM, Michael NP, Melton RG, Ford MJ, Young LS, Kerr DJ, Searle PF (1997) Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by retroviral transduction and expression of the E. coli nitroreductase gene. Cancer Gene Ther 4:229–238
Gusterson B, Cui W, Iwobi M, Harold G, Hobbs S, Kamalati T, Knox R, Neil C, Howard B, Clark B (1997) selective cell ablation in the mammary gland of transgenic mice. Endocr Relat Cancer 4:67–74
Harris S, McClenaghan M, Simons JP, Ali S, Clark AJ (1991) Developmental regulation of the sheep β-lactoglobulin gene in the mammary gland of transgenic mice. Dev Genet 12:299–307
Isles AR, Ma D, Milsom C, Skynner M, Cui W, Clark J, Keverne EB, Allen ND (2001) A novel strategy for conditional ablation of neurons in transgenic mice. J Neurobiol 47:183–193
Knox RJ, Friedlos F, Jarman M, Roberts JJ (1988) A new cytotoxic agent DNA interstrand crosslinking agent 5′ (aziridin-1-yl)-4-hydroxylamino-2-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells. Biochem PharmacoI 37:4661–4669
Knox RJ, Friedlos F, Marchbank F, Roberts JJ (1992) The bioactivation of CB 1954.Acomparison of an Escherichia coli nitroreductase and Walker DT diaphorase. Biochem Pharmacol 44:2297–2301
Knox RJ, Friedlos F, Boland M (1993) The bioactivation of CB 1954 and its use as a prodrug in antibody directed enzyme pro-drug therapy. Cancer Metastasis Rev 12:195–212
Kuwada J, Goodman CS (1985) Neuronal determination during embryonic development of the grasshopper nervous system. Dev Biol 110:114–126
Lamb FI, Roberts LM, Lord MJ (1985) Nucleotide sequence of cloned cDNA coding for preporicin. Eur J Biochem 148:265–270
Landel CP, Zhao J, Bok D, Evans GA (1988) Lens-specific expression of recombinant ricin induces developmental defects in the eyes of transgenic mice. Genes Dev 2:1168–1178
Largo C, Cuevas P, Herreras O (1996) Is glia dysfunction the initial cause of neuronal death in ischemic penumbra? Neurol Res 18:445–448
Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopam inergic neurons. Science 260:1130–1132
Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H (1992) Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 117:395–400
Lohs-Schardin M, Cremer C, Nusslein-Volhard C (1979) A fate map for the larval epidermis of Drosophila melanogaster: localized cuticle defects following irradiation of blastoderm with an ultraviolet laser microbeam. Dev Biol 73:239–255
Miller JP, Selverson AI (1979) Rapid killing of single neurons by irradiation of intracellularly injected dye. Science 206:702–704
Monaghan DT, Bridges RJ, Cotman CW (1989) The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365–402
Morrison ME, Mason CA (1998) Granule neuron regulation of Purkinje cell development: striking a balance between neurotrophin and glutamate signaling. J Neurosci 18:3563–3573
Mulligan RC, Berg P (1980) Expression of a bacterial gene in mammalian cells. Science 209:1422–1427
Palmiter RD, Behringer RR, Quaife CJ, Maxwell F, Maxwell IH, Brinster RL (1987) Cell lineage ablation in transgenic mice by cell specific expression of a toxin gene. Cell 50: 435–443
Pappenheimer AM Jr (1977) Diphtheria toxin. Annu Rev Biochem 46:69–94
Porter JT, McCarthy KD (1997) Astrocytic neurotransmitter receptors in situ and in vivo. Prog NeurobioI 51:439–455
Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD (1993) Programmed cell death and the control of cell survival: lesions from the nervous system. Science 262:695–700
Rakic P (1971) Neuron-glia relationship during granule cell migration in developing cerebellar cortex: a Golgi and electronmicroscopic study in Macacus Rhesus. J Comp Neurol 141:283–312
Robertson G, Garrick D, Wu W, Kearns M, Martin D, Whitelaw E (1995) Position-dependent variegation of globin transgene expression in mice. Proc Natl Acad Sci U SA 92:5371–5375
Rosenberg PA, Aizenman E (1989) Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci Lett 103:162–168
Rosenberg PA (1991) Accumulation of extracellular glutamate and neuronal death in astrocyte-poor cortical cultures exposed to glutamine. Glia 4:91–100
Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW (1994) Localization of neuronal and glial glutamate transporters. Neuron 13:713–725
Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Iin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke IP, Welty DF (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675–686
Salomon B, Maury S, Loubiere L, Caruson M, Onclerq R, Klatzman O (1995) A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogues and does not cause sterility in transgenic mice. Mol Cell Biol 15:5322–5328
Simons JP, McClenaghan M, Clark AJ (1987) Alteration of the quality of milk by expression of sheep,β-lactoglobulin in transgenic mice. Nature 328:530–532
Smith H (1989) Pattern regulation during the development of the ventral abdomen in the flesh fly Sarcophaga agryostoma. Development 105:35–342
Stamps AC, Davies SC, Burman J, O’Hare MJ (1994) Analysis of proviral integration in human mammary epithelial cell lines immortalized by retroviral infection with a temperature-sensitive SV40 T-antigen construct. Intl J Cancer 57:865-874
Storck T, Schulte S, Hofmann K, Stoffel W (1992) Structure, expression and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89:10955–10959
Sugiyama K, Brunori A, Mayer ML (1989) Glial uptake of excitatory amino acids influences neuronal survival in cultures of mouse hippocampus. Neuroscience 32:779–791
Sweetser DA, Hauft SM, Hoppe PC, Birkenmeier EH, Gordon JI (1988) Transgenic mice containing intestinal fatty acid binding protein human growth hormone fusion gene exhibit correct regional and cell specific expression of the reporter gene in the intestine. Proc Natl Acad Sci U S A 85:9611–9615
Traugott U, Lebon P (1988) Multiple sclerosis: involvement of interferons in lesion pathogenesis. Ann Neurol 24:243–251
Traurig H (1967) A radioautographic study of cell proliferation in the mammary gland of the pregnant mouse. Anat Rec 159:239–248
Wallace H, Clarke AR, Harrison OJ, Hooper ML, Bishop JO (1996) Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpes virus thymidine kinase occurs by p53 independent apoptosis. Oncogene 13:55–61
Watase K, Hashimoto K, Kano M, Yamada K, Watanabe M, Inoue Y, Okuyama S, Sakagawa T, Ogawa S, Kawashima N, Hori S, Takimoto M, Wada K, Tanaka K (1998) Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Eur J Neurosci 10:976–988
Workman P, White RAS, Talbot K (1986a) CB 1954 revisited. I: disposition kinetics and metabolism. Cancer Chemother Pharmacol 16:1–8
Workman P, White RAS, Talbot K (1986b) CB 1954 revisited. II: toxicity and antitumour activity. Cancer Chemother Pharmacol 16:9–14
Yull F, Harold G, Cowper A, Percy J, Cottingham I, Clark AJ (1995) Fixing human factor IX (fIX): correction of a cryptic Rna splice enables the production of biologically active human factor IX in the mammary gland. Proc Natl Acad Sci U S A 92:10899–10903
Yuzaki M, Mikoshiba K, Kagawa Y (1993) Cerebellar astrocytes specifically support the survival of Purkinje cells in culture. Biochem Biophys Res Commun 197:123–129
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gusterson, B.A., Cui, W., Clark, A.J. (2003). Development of Novel Selective Cell Ablation in the Mammary Gland and Brain to Study Cell-Cell Interactions and Chemoprevention. In: Senn, HJ., Morant, R. (eds) Tumor Prevention and Genetics. Recent Results in Cancer Research, vol 163. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55647-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-55647-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62892-4
Online ISBN: 978-3-642-55647-0
eBook Packages: Springer Book Archive